Sartorius Stedim Biotech Stock Price Patterns

SDMHF Stock  USD 207.00  5.50  2.59%   
As of 15th of February 2026, the relative strength index (RSI) of Sartorius Stedim's share price is approaching 30. This usually implies that the pink sheet is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Sartorius Stedim, making its price go up or down.

Momentum 30

 Sell Stretched

 
Oversold
 
Overbought
The successful prediction of Sartorius Stedim's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Sartorius Stedim and does not consider all of the tangible or intangible factors available from Sartorius Stedim's fundamental data. We analyze noise-free headlines and recent hype associated with Sartorius Stedim Biotech, which may create opportunities for some arbitrage if properly timed.
Using Sartorius Stedim hype-based prediction, you can estimate the value of Sartorius Stedim Biotech from the perspective of Sartorius Stedim response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Sartorius Stedim to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Sartorius because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Sartorius Stedim after-hype prediction price

    
  USD 207.0  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Sartorius Stedim Basic Forecasting Models to cross-verify your projections.
Intrinsic
Valuation
LowRealHigh
204.83207.00209.17
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Sartorius Stedim. Your research has to be compared to or analyzed against Sartorius Stedim's peers to derive any actionable benefits. When done correctly, Sartorius Stedim's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Sartorius Stedim Biotech.

Sartorius Stedim After-Hype Price Density Analysis

As far as predicting the price of Sartorius Stedim at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Sartorius Stedim or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Sartorius Stedim, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Sartorius Stedim Estimiated After-Hype Price Volatility

In the context of predicting Sartorius Stedim's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Sartorius Stedim's historical news coverage. Sartorius Stedim's after-hype downside and upside margins for the prediction period are 204.83 and 209.17, respectively. We have considered Sartorius Stedim's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
207.00
204.83
Downside
207.00
After-hype Price
209.17
Upside
Sartorius Stedim is very steady at this time. Analysis and calculation of next after-hype price of Sartorius Stedim Biotech is based on 3 months time horizon.

Sartorius Stedim Pink Sheet Price Outlook Analysis

Have you ever been surprised when a price of a Company such as Sartorius Stedim is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Sartorius Stedim backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Sartorius Stedim, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.11 
2.17
 0.00  
 0.00  
0 Events / Month
0 Events / Month
Within a week
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
207.00
207.00
0.00 
0.00  
Notes

Sartorius Stedim Hype Timeline

Sartorius Stedim Biotech is at this time traded for 207.00. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Sartorius is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at -0.11%. %. The volatility of related hype on Sartorius Stedim is about 36166.67%, with the expected price after the next announcement by competition of 207.00. About 74.0% of the company outstanding shares are owned by corporate insiders. The company recorded earning per share (EPS) of 7.94. Sartorius Stedim Biotech last dividend was issued on the 31st of March 2022. The entity had 6:1 split on the 6th of May 2016. Assuming the 90 days horizon the next forecasted press release will be within a week.
Check out Sartorius Stedim Basic Forecasting Models to cross-verify your projections.

Sartorius Stedim Related Hype Analysis

Having access to credible news sources related to Sartorius Stedim's direct competition is more important than ever and may enhance your ability to predict Sartorius Stedim's future price movements. Getting to know how Sartorius Stedim's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Sartorius Stedim may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
TRUMYTerumo Corp ADR 0.00 0 per month 0.00 (0.11) 2.18 (3.04) 9.19 
TRUMFTerumo 0.00 0 per month 0.00 (0.05) 12.03 (9.73) 25.58 
SUVPFSartorius Aktiengesellschaft 0.00 0 per month 1.93  0.01  1.82 (1.89) 24.69 
CLPBFColoplast AS 0.00 0 per month 0.00 (0.11) 3.14 (5.72) 12.23 
CLPBYColoplast A 0.00 0 per month 0.00 (0.17) 1.73 (2.70) 9.98 
SAUHYStraumann Holding AG 0.00 0 per month 1.67 (0) 3.78 (2.68) 9.67 
SAUHFStraumann Holding AG 0.00 0 per month 2.50  0.03  6.62 (5.22) 14.48 
SARTFSartorius Aktiengesellschaft(0.06)3 per month 0.00  0.04  0.00  0.00  11.96 
SSSGYSartorius Aktiengesellschaft 0.00 0 per month 0.00  0.09  1.97  0.00  25.74 
OTSKFOtsuka Holdings Co 0.00 0 per month 0.00  0.02  0.64  0.00  9.16 

Sartorius Stedim Additional Predictive Modules

Most predictive techniques to examine Sartorius price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Sartorius using various technical indicators. When you analyze Sartorius charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Sartorius Stedim Predictive Indicators

The successful prediction of Sartorius Stedim stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Sartorius Stedim Biotech, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Sartorius Stedim based on analysis of Sartorius Stedim hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Sartorius Stedim's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Sartorius Stedim's related companies.

Currently Active Assets on Macroaxis

Complementary Tools for Sartorius Pink Sheet analysis

When running Sartorius Stedim's price analysis, check to measure Sartorius Stedim's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sartorius Stedim is operating at the current time. Most of Sartorius Stedim's value examination focuses on studying past and present price action to predict the probability of Sartorius Stedim's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sartorius Stedim's price. Additionally, you may evaluate how the addition of Sartorius Stedim to your portfolios can decrease your overall portfolio volatility.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
AI Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing